The aim of this study was to determine whether the expression of PD-1/PD-L1/PD-L2 on PBMCs, particularly on T-cell subsets, was associated with different survival outcomes in NSCLC patients. This evidence concerns the gene PDCD1 and non-small cell lung carcinoma.